Table of Content

1. Market Definition & Scope
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.3. Direct-to-consumer Laboratory Testing Market: Regulatory Analysis
4.3.1. Overview
4.3.2. North America
4.3.2.1. U.S.
4.3.2.2. Canada
4.3.3. Europe
4.3.4. Asia-Pacific
4.3.4.1. China
4.3.4.2. Japan
4.3.4.3. India
4.3.5. Latin America
4.3.6. Middle East
4.4. Direct-to-consumer Laboratory Testing Market: Pricing Analysis
4.5. Case Studies
4.5.1. DTC Genetic Testing Companies Adapting to the Industry Slowdown
4.6. Industry Trends
4.6.1. Declining Costs of Sequencing to Make DTC Genetic Testing More Accessible
4.6.2. Shift from Physician-driven to Consumer-driven Healthcare

5. Direct-to-consumer Laboratory Testing Market Assessment?by Application
5.1. Overview
5.2. Genetic Testing
5.2.1. Ancestry/Genealogy
5.2.2. Disease Risk Assessment
5.2.2.1. Cancer
5.2.2.2. Cardiovascular Diseases
5.2.2.3. Neurological Diseases
5.2.2.4. Other Diseases
5.2.3. Carrier Status
5.2.4. Other Genetic Tests
5.3. Diabetes Testing
5.4. Routine Clinical Testing
5.5. Thyroid Function Testing
5.6. COVID-19 Testing
5.7. Sexually Transmitted Disease Testing
5.8. Other Applications

6. Direct-to-consumer Laboratory Testing Market Assessment?by Sample Type
6.1. Overview
6.2. Blood
6.3. Saliva
6.4. Urine
6.5. Other Samples

7. Direct-to-consumer Laboratory Testing Market Assessment?by Geography
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.3. Europe
7.3.1. U.K.
7.3.2. Germany
7.3.3. Italy
7.3.4. France
7.3.5. Spain
7.3.6. Rest of Europe (RoE)
7.4. Asia-Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia-Pacific (RoAPAC)
7.5. Latin America
7.6. Middle East & Africa

8. Competition Analysis
8.1. Overview
8.2. Key Growth Strategies
8.3. Competitive Dashboard
8.3.1. Industry Leaders
8.3.2. Market Differentiators
8.3.3. Vanguards
8.3.4. Emerging Companies
8.4. Vendor Benchmarking
8.5. Market Share Analysis (2022)
8.5.1. Ancestry.com, LLC (U.S.)
8.5.2. Laboratory Corporation of America Holdings (U.S.)
8.5.3. 23andMe Holding Co. (U.S.)
8.5.4. Quest Diagnostics Incorporated (U.S.)

9. Company Profiles
9.1. Quest Diagnostics Incorporated
9.2. Laboratory Corporation of America Holdings
9.3. 23andMe Holding Co.
9.4. Myriad Genetics, Inc.
9.5. Everlywell, Inc. (A Subsidiary of Everly Health, Inc.)
9.6. DirectLabs, LLC
9.7. Ancestry.com, LLC
9.8. MyMedLab, Inc.
9.9. ANY LAB TEST NOW
9.10. Thorne Healthtech, Inc.
9.11. LetsGetChecked, Inc.
9.12. Other Companies

10. Appendix
10.1. Available Customization
10.2. Related Reports



List of Figures

List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Direct-to-consumer Laboratory Testing Market Size, by Application, 2023 Vs. 2030 (USD Million)
Figure 8 Global Direct-to-consumer Laboratory Testing Market Size, by Sample Type, 2023 Vs. 2030 (USD Million)
Figure 9 Direct-to-consumer Laboratory Testing Market Size, by Geography
Figure 10 U.S.: Regulations for DTC Laboratory Testing
Figure 11 Types of Direct-to-consumer Tests and Their Regulatory Pathways
Figure 12 Genome Sequencing Costs, 2010–2021 (USD)
Figure 13 Global Direct-to-consumer Laboratory Testing Market, by Application, 2023–2030 (USD Million)
Figure 14 Process of DTC Genetic Testing
Figure 15 Estimated Number of New Cancer Cases (2020–2040)
Figure 16 Global Direct-to-consumer Laboratory Testing Market, by Sample Type, 2023 Vs. 2030 (USD Million)
Figure 17 Benefits of Saliva Sampling
Figure 18 Global Direct-to-consumer Laboratory Testing Market, by Region, 2023 Vs. 2030 (USD Million)
Figure 19 North America: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 20 U.S.: Disposable Personal Income (USD Billion)
Figure 21 Europe: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 22 U.K.: Number of New Sexually Transmitted Infections Diagnosed Per 100,000 Population
Figure 23 Italy: Percentage of Population Aged 65 & Above
Figure 24 Spain: Number of People Living with HIV (2010-2021)
Figure 25 Asia-Pacific: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 26 Japan: Percentage of Population Aged 65 and Above (2010–2030)
Figure 27 Brazil: Number of People with Diabetes (In Thousands)
Figure 28 Argentina: HIV Statistics
Figure 29 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 30 Competitive Dashboard: Direct-to-consumer Laboratory Testing Market
Figure 31 Direct-to-consumer Laboratory Testing Market: Vendor Benchmarking, by Application
Figure 32 Direct-to-consumer Laboratory Testing Market: Vendor Benchmarking, by Region
Figure 33 Global Direct-to-consumer Laboratory Testing Market Share Analysis, by Key Players, 2022 (%)
Figure 34 Quest Diagnostics Incorporated.: Financial Overview (2022)
Figure 35 Laboratory Corporation of America Holdings: Financial Overview (2022)
Figure 36 23andMe Holding Co.: Financial Overview (2021)
Figure 37 Myraid Genetics, Inc: Financial Overview (2022)
Figure 38 Thorne Healthtech, Inc.: Financial Overview (2022)